SEATTLE--(BUSINESS WIRE)--Amp Orthopedics, a privately held medical device company, announced the initiation of two well-controlled clinical trials, one evaluating patients undergoing total knee replacement and a second in patients having arthroscopic rotator cuff repair surgery. The goal of these randomized, double-blinded, sham-controlled trials is to determine the safety and effectiveness of the company’s non-thermal pulsed radio frequency (PRF) technology to reduce narcotic (opioid) use, decrease pain, and improve function and quality of life following these surgical procedures. Results of both trials are anticipated in 2012.
